This new SCLC-I subset was defined by an inflamed gene signature that included immune checkpoint molecules (PD-L1, PD-1, CTLA-4, TIGIT, VISTA, ICOS, LAG3), genes encoding HLAs, as well as the chemokines CCL5 and CXCL10. The gene discussed is CD274; the disease is small cell lung carcinoma.